Article in The Scientist featuring Dr. Malú Tansey examines COVID-19's impact on recruiting.
Dr. Michael Okun co-authored a new JAMA Neurology Viewpoint article discussing COVID-19’s impact on health care delivery.
In a recent study, a team of UF neuroscientists and biomedical engineers compared beta dynamics in two Parkinson's disease deep brain stimulation (DBS) targets.
Neurocritical care experts offer insight into potential neurologic complications of severe respiratory viruses, including COVID-19.
Dr. Michael Okun discusses new JAMA Parkinson’s disease review co-authored with Dr. Melissa Armstrong.
Read about the highly anticipated acquisition of three top neuroscientists at UF Health in the latest edition of Florida Physician.
Read how personal relationships can lead to breakthroughs that impact lives in the latest edition of Florida Physician.
In The Conversation, Drs. Katharina Busl and Carolina Maciel weigh in on a new study suggesting that brain activity measured by EEG may provide a key indicator to predict a patient’s likelihood of recovering from an acute brain injury.
In the journal JAMA Neurology, Dr. Michael Okun discusses the challenge of selecting an appropriate DBS system for an individual patient.
Dr. James Wymer among national team of researchers to identify novel pathway for potential treatment of the disfiguring condition, neurofibromatosis 1.